WHY WE INVEST
We estimate that the U.S. spends about USD 20 billion a year on cancer research, but only 0.5 percent of that goes toward translating research out of the lab and into the real world, where it can change and save lives.
The AIM-HI Accelerator Fund finds the innovators and inventors on the cusp of revolutionizing cancer prevention and care, and gives them the funding they need to bring their breakthroughs to life.
The companies we fund are out to:
We convene best-in-class entrepreneurs, researchers, philanthropists, impact investors, and thought leaders who are passionate about the future of cancer care and want to take action today. They are investors in the cure, who take a stake in businesses that could be game changers.
Our investors have unique opportunities to engage with AIM-HI and the startups we fund.